ClearStar, Inc. is a leading and trusted background check technology, strategic services, and decision-making information provider to employers and background screening companies.
Recovering faster than anticipated
Price can often be a poor indicator of value, especially during uncertain times & for smallcap stocks. So it is for specialist US background screening & medical testing firm ClearStar. Indeed despite the shares dropping on low volume, the company has actually traded much better than we had previously thought possible.
Not only “experiencing a significant uptick in sales from the end of May, which has continued into July”. But also generating positive EBITDA (pre SBPs) between May & June, along with being largely cashflow neutral – net debt coming in at $1.4m on 30th June (liquidity $2.2m) vs $1.5m 15th June & $1.0m 5th May 2020.
Through the worst of the pandemic
Promising news, particularly given America has just experienced its steepest decline in employment ever. Moreover, regardless of the recent rise in Covid infections as businesses reopen, progress towards finding an effective medical solution – eg vaccine (Moderna, Oxford Uni/AstraZeneca, J&J, Pfizer) &/or therapeutic (Regeneron) – is progressing at speed.
Meaning that many of the 20.7m jobs lost (see below, non-farm payrolls) in April, or equivalent to 10.3% of the workforce, should be return over the next 12–24 months.
June sales rebound to February levels
In fact, this is already happening, with CLSU’s June turnover jumping 74% vs April, equivalent to February levels. Driven by financial institutions (eg Wall Street investment bank), an HR outsourcing group (NYSE listed, $2.6bn mrkcap) and greater demand for medical testing (MIS).
What’s more, in the absence of another round of widespread ‘stay at home orders’ – which we don’t think will occur, or is necessary – then coupled with tight cost control, these favourable trends should continue throughout H2 & beyond.
Lastly with regards to valuation, the shares (at 33p) trade on a modest 2019 EV/revs of 0.7x vs peers (pre coronavirus) at 2.5x–3.5x. We believe this ratings gap is unjustified & will close over the next 1-2 years, as Clearstar delivers strong top line growth - complemented by improved operational gearing, reflecting cost savings that should ensure post-pandemic.Download Now Missing Out Get our research first
WHY CHOOSE ED
"Many thanks to @equity_research for a superb Investor Forum. $BMK.L , $VLG.L & $VP.L all interesting companies. I recommend these events. "
"We cannot thank you enough for opening our eyes to private investors."
"MHP believes commissioned research is an important part of the toolkit to attract new investors and improve liquidity. We rate ED's analysts and research very highly as one of the leading providers in this space."
"One of the biggest problems private investors have, is getting access to broker research. It’s basically impossible for many investors. Therefore I feel some commissioned research is really important and a good investment for companies. In my experience ED are far more proactive than other firms in this space."
Blogger and Stockopedia Contributor
"There is a need now, more than ever before, for real insight and clarity to be brought to company messages for investors….I would strongly recommend Equity Development to the management of any company."
Small Cap Equity Salesman
"From early days as a private company through to being established on AIM, I have always been able to rely on ED for wise counsel, perceptive research and introductions to new, supportive shareholders."
"I would like to thank and congratulate you, particularly Liz, on your note. It’s short, sharp, pulls out the key issues and I believe will be a valuable asset for our retail outreach."
"The team at ED consistently produce high quality research and highlight profitable investment opportunities, an invaluable tool for small cap investors in this under researched space."
"I thoroughly enjoyed the investor evening again, and as before its good that you get such an interested audience who engage and ask us all decent questions."